Normal view MARC view ISBD view

In silico screenng of FDA-approved drugs and natural proteins of omicron and design of new inhibitors for main protease (Mpro) of SARS-CoV-2

Jyoti Mishra

In silico screenng of FDA-approved drugs and natural proteins of omicron and design of new inhibitors for main protease (Mpro) of SARS-CoV-2 - 2022 - 49

Subjects--Topical Terms:
Physical Science

Place hold
Print
Add to your cart (remove)
Suggest for purchase
Save record
BIBTEX Dublin Core MARCXML MARC (non-Unicode/MARC-8) MARC (Unicode/UTF-8) MARC (Unicode/UTF-8, Standard) MODS (XML) RIS ISBD
More searches

Search for this title in:
Other Libraries (WorldCat) Other Databases (Google Scholar) Online Stores (Bookfinder.com) Open Library (openlibrary.org)